Investorideas.com  big ideas for global investors Search www.investorideas.com
   Member Access       Sign-up       Listings        Stock Directories       Research       Cleantech       Tech Newsletter         Headlines        Video       New Ventures   




Zenosense, Inc. (ZENO) Set to Help Healthcare Providers Contain MRSA-Related Treatment Costs

Ideas get bigger when you share them...

July 7, 2014 (www.investorideas.com newswire) In the United States, treatment costs of hospitalized MRSA patients run as high as $4.2 billion per year. For a patient who has an MRSA infection, a hospital stay is likely to be three times longer than one by an uninfected patient, at three times the cost. An MRSA-infected patient is also five times more likely to die than an uninfected party.

Join Investor Ideas Members to access the Renewable Energy stocks directory, water stocks, biotech stocks, defense stocks directories and the Insiders Corner

Zenosense, a healthcare technology company, is focused on developing a sensory device that detects MRSA bacterial contamination in patients. To that end, Zenosense has partnered with a respected sensor developer, Sgenia Group, to address this multibillion-dollar medical issue. The sensory device will function as a "smoke alarm" for MRSA, or uses an electronic nose to monitor and detect any airborne Volatile Organic Compounds (VOC) signature emitted by MRSA. It will be deployed for use in healthcare settings or other locations in which MRSA may pose a medical risk. By detecting MRSA in its early stages of development, healthcare providers will be able to minimize the heavy-handed costs of treatment associated with late-stage MRSA patient infection.

At present, there are devices for detection of incidences of this bacterial contamination, but they pose significant expense burdens for healthcare providers and are bulky in size, which minimizes advantages that could come with great setting mobility. Zenosense's coming innovation, on the other hand, will be a wearable device, giving healthcare providers more flexibility in being able to deploy it to different patient locations with greater ease. On top of its advantage of mobility, the sensory device will make use of a technologically-potent, single sensor that has an advanced VOC-detecting capability equivalent to tens of thousands of sensors. While detection devices currently available cost around $8,000 each, Zenosense anticipates being able to manufacture the device at less than $100 per unit.

On top of MRSA detection, Zenosense has also extended its agreement with Sgenia Group to develop devices that detect VOC signatures given off by certain types of cancer, such as lung cancer. Current medical estimates show many cases of lung cancer being detected in its later stages, but earlier detection could lead to a patient cure rate of 70 percent.

For more information on the company visit www.zenosense.net

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for "The QualityStocks Daily Newsletter" at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks "Ones to Watch" http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Kallo, Inc. (KALO) MobileCare™ Solution, Supporting Technology Provides Invaluable Continuing Education

Continuing education and maintaining familiarity with the latest advances, developments and technologies is of upmost importance in any segment of the healthcare field. With this in mind, Kallo, Inc. is collaborating with U.S. and Canadian academia to design education and training programs that will heighten the skills of healthcare professionals as well as the company's own employees.

Supported by a management team with entrepreneurship, experience and knowledge of healthcare, Kallo aims to increase the quality and reach of medical treatment in remote areas. To execute this mission, the company has developed a portfolio of clinical solutions in compliance with international, national and regional standards.

Kallo's MobileCare™ is a comprehensive solution for remote and/or unreached communities. The mobile clinics are loaded with best-in-class medical devices and corresponding information systems. Contributing to further education, the MobileCare product also includes a training program to ensure a successful grafting of medical and technical best practices from around the world.

MobileCare is linked via telehealth, which uses advanced diagnostic video conferencing to enable patient-physician/specialist interaction in real-time over unlimited distances. For healthcare professionals in rural areas, this technology provides invaluable secondary support and the opportunity to increase medical knowledge and practices.

The telehealth systems provide access to diagnostic, surgical and technical guidance from specialists at Clinical Command Centers that are located at the nearest teaching hospital, enabling specialists to provide care to patients in unreached remote areas. Armed with this field support and access to MobileCare's cutting-edge medical equipment and technology, trained and certified staff will be able to perform tasks that are not usually performed by technicians.

The Kallo Clinical Transformation Team, comprised of doctors, nurses, bio-medical engineers, partnered with academia to develop specific training programs for MobileCare to educate medical professionals on the use of onboard equipment and best-practice procedures and protocol.

Nurses are provided continuing medical education in areas such as monitoring and tracking vital signs, IV placement, phlebotomy, administration of medications and more. MobileCare also provides training for local technicians on how to install, repair, calibrate, inspect and provide maintenance on all technical equipment within the mobile clinic. Furthermore, mobile clinic operators are trained to perform level-one equipment troubleshooting and to oversee the transformation of the clinic into an aseptic environment.

Through integration with current healthcare infrastructures, MobileCare optimizes the scope and efficiency of healthcare by delivering higher standards via latest technologies. The solution equips medical personnel with the equipment and technology to advance medical care in remote or disaster-stricken areas, filling a dire need within the broader healthcare industry.

For more information, visit www.kalloinc.ca

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for "The QualityStocks Daily Newsletter" at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks "Ones to Watch" http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

More Info:

This news is published on the Investorideas.com Newswire and its syndicated partner network

Publish Your News - Send a release
News now!

Get free news alerts: Sign up here

Published at the Investorideas.com Newswire - Big ideas for Global Investors

Disclaimer/ Disclosure:The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp

BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.



Free News Alerts
Email:  

Read more News





TOP

Investor Ideas © 2000 - 2014 InvestorIdeas.com®, ECON

Free Investor Stock Alerts
Sign up here

login | logout | about us | contact | disclaimer / disclosure |
advertise | company profile directory | partners / links |
job search | privacy policy | trade | services | sitemap |